MUMBAI, March 15 (Reuters) – U.S. consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with…
The post P&G stops selling Vicks Action 500 Extra in India after ban appeared first on NASDAQ.